A commentary notes that the main limitation of this systematic review is the heterogeneity of included studies. The author highlights that whilst oral immunotherapy reduces the likelihood of reacting to peanuts in a controlled clinic setting, its overall side-effect profile means that patients seem to have more allergic reactions while on therapy.